Richard Pye | Investor Relations |
Glyn Edwards | Chief Executive Officer |
David Roblin | Chief Operating Officer and President of Research & Developments |
Erik Ostrowski | Chief Financial Officer |
Arlinda Lee | Canaccord Genuity |
Tim Chiang | BTIG |
Debjit Chattopadhyay | H.C. Wainwright |
Samir Devarni | RX Securities |
John Gillings | JMP Securities |
Julie Simmonds | Panmure Gordon |
Good day. And welcome to the Summit Therapeutics' Conference Call on the Financial Results for the Fourth Quarter and Fiscal Year-ended, 31 January 2018 and Operational Progress. Today's conference is being recorded. At this time, I would like to turn the conference over to Mr. Richard Pye, Senior Director of Corporate Affairs and Communications.